SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-040819
Filing Date
2020-08-20
Accepted
2020-08-20 16:51:04
Documents
63
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q nktx-10q_20200630.htm 10-Q 2478683
2 EX-10.5 nktx-ex105_289.htm EX-10.5 81613
3 EX-10.6 nktx-ex106_290.htm EX-10.6 77149
4 EX-31.1 nktx-ex311_6.htm EX-31.1 18602
5 EX-31.2 nktx-ex312_7.htm EX-31.2 17904
6 EX-32 nktx-ex321_8.htm EX-32.1 14881
  Complete submission text file 0001564590-20-040819.txt   7518482

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT nktx-20200630.xml EX-101.INS 1427896
8 XBRL TAXONOMY EXTENSION SCHEMA nktx-20200630.xsd EX-101.SCH 48157
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nktx-20200630_cal.xml EX-101.CAL 54856
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nktx-20200630_def.xml EX-101.DEF 168208
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE nktx-20200630_lab.xml EX-101.LAB 385818
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nktx-20200630_pre.xml EX-101.PRE 308955
Mailing Address 6000 SHORELINE COURT SUITE 102 SOUTH SAN FRANCISCO CA 94080
Business Address 6000 SHORELINE COURT SUITE 102 SOUTH SAN FRANCISCO CA 94080 650-215-0385
Nkarta, Inc. (Filer) CIK: 0001787400 (see all company filings)

IRS No.: 474515206 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39370 | Film No.: 201120586
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences